Skip to main content
71°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
May 16, 2025
Tags
Europe News
Breaking News: Europe
Pharmaceuticals
From
CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
May 15, 2025
Tags
Europe Politics
Bayer AG
International: Top News And Analysis
From
CNBC.com News
Why Americans pay so much more for prescription drugs
May 14, 2025
Tags
LILLY DRN
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
May 07, 2025
Tags
Health care industry
Health & Science
Social issues
From
CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
May 07, 2025
Tags
LILLY DRN
Business News
Biotechnology
From
CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
May 06, 2025
Tags
Make It
Make It: Next Gen Investing
Make It / Money
From
CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
May 05, 2025
Tags
Novo Nordisk A/S
Hims & Hers Health Inc
Enterprise
From
CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
May 02, 2025
Tags
Dutch Bros Inc
Business
Palantir Technologies Inc
From
CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 02, 2025
Tags
Abbvie Inc
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
May 01, 2025
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
April 29, 2025
Tags
Business
Health & Science
Pharmaceuticals
From
CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
April 25, 2025
Tags
Companies
Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
April 22, 2025
Tags
Healthy Returns
Centene Corp
Pfizer Inc
From
CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
April 22, 2025
Tickers
OIL
Tags
Stellantis NV
ASML Holding NV
Markets
From
CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17, 2025
Tags
AstraZeneca PLC
Business
Health & Science
From
CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
April 14, 2025
Tags
World Markets
JPMorgan Chase & Co
Market Outlook
From
CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
April 14, 2025
Tags
Pfizer Inc
Health & Science
Business
From
CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
April 10, 2025
Tags
Business
Europe News
Breaking News: Politics
From
CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
April 04, 2025
Tags
Health & Science
Social issues
Business
From
CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
April 03, 2025
Tags
World economy
Trade
LVMH Moet Hennessy Louis Vuitton SE
From
CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
April 03, 2025
Tags
Pharmaceuticals
AstraZeneca PLC
Bayer AG
From
CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
March 29, 2025
Tags
Business
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
March 28, 2025
Tags
Biotech and Pharmaceuticals
LILLY DRN
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
March 27, 2025
Tags
Pharmaceuticals
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
March 26, 2025
Tags
Novo Nordisk A/S
SAP AG
Tesla Inc
From
CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
March 25, 2025
Tags
Market Outlook
World Markets
Tesla Inc
From
CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
Tags
Healthy Returns
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
March 25, 2025
Tags
Europe Markets
Novo Nordisk A/S
Markets
From
CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Roche Holding AG
From
CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
March 24, 2025
Tags
Novo Nordisk A/S
Biotechnology
Business News
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.